-
Signature
-
/s/ Ben Hohl, by power of attorney
-
Stock symbol
-
ELVN
-
Transactions as of
-
Jun 3, 2025
-
Transactions value $
-
-$150,220
-
Form type
-
4
-
Date filed
-
6/5/2025, 04:55 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Lyssikatos Joseph P |
CHIEF SCIENTIFIC OFFICER |
C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER |
/s/ Ben Hohl, by power of attorney |
2025-06-05 |
0001967150 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ELVN |
Common Stock |
Sale |
-$150K |
-7.5K |
-0.76% |
$20.03 |
978K |
Jun 3, 2025 |
See footnote |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: